Revolution Medicines (RVMDW) Asset Utilization Ratio (2020 - 2024)
Revolution Medicines (RVMDW) posted quarterly Asset Utilization Ratio of 0.0 for Q3 2024, down 96.79% year-over-year from 0.03 in Q4 2023, and up 7.99% quarter-over-quarter from 0.0 in Q2 2024.
Revolution Medicines (RVMDW) Asset Utilization Ratio (2020 - 2024) Analysis & Trends
Revolution Medicines' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.0 for Q3 2024.
- In Q3 2024, Asset Utilization Ratio fell 96.79% year-over-year to 0.0; the TTM figure through Sep 2024 stood at 0.0 (down 96.79% YoY), while the FY2023 annual figure was 0.01, down 82.35% from the prior year.
- Asset Utilization Ratio for Q3 2024 stood at 0.0, up from 0.0 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.14 in Q1 2020, with the low at 0.0 in Q2 2024.
- The 5-year median for Asset Utilization Ratio is 0.04 (2021), against an average of 0.05.
- The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio rose 8.26% in 2022, then slumped 97.25% in 2024.
- Revolution Medicines' Asset Utilization Ratio stood at 0.07 in 2020, then slumped by 46.04% to 0.04 in 2021, then advanced by 8.26% to 0.04 in 2022, then sank by 82.4% to 0.01 in 2023, then plunged by 89.27% to 0.0 in 2024.
- Business Quant data shows RVMDW's Asset Utilization Ratio at 0.0 in Q3 2024, 0.0 in Q2 2024, and 0.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Revolution Medicines | 2.45 Bn | 2.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | 0.05 |
| Mar 31, 2021 | 0.06 |
| Dec 31, 2020 | 0.07 |
| Sep 30, 2020 | 0.09 |
| Jun 30, 2020 | 0.10 |
| Mar 31, 2020 | 0.14 |